Viral infections and antiphospholipid antibodies
Objective: To study the relationship between viral infections and the induction of antiphospholipid (aPL) antibodies. Methods: We reviewed the medical literature from 1968 until 2000 using MEDLINE and the key words virus, infection, antiphospholipid, and anticardiolipin. Results: Anticardiolipin ant...
Gespeichert in:
Veröffentlicht in: | Seminars in arthritis and rheumatism 2002-02, Vol.31 (4), p.256-263 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Objective: To study the relationship between viral infections and the induction of antiphospholipid (aPL) antibodies. Methods: We reviewed the medical literature from 1968 until 2000 using MEDLINE and the key words virus, infection, antiphospholipid, and anticardiolipin. Results: Anticardiolipin antibodies and/or lupus anticoagulant were associated with a number of viral infections, including hepatitis C virus, human immunodeficiency virus, cytomegalovirus, varicella zoster, Epstein-Barr virus, adenovirus, and parvovirus B. In many instances, the presence of these antibodies was associated with thrombosis. Conclusion: The clinical significance of finding aPL antibodies in patients with viral infections remains unknown. In some patients, these antibodies may be transient and disappear within 2 or 3 months. In other susceptible individuals, they may persist and raise the question of whether infections may trigger the development of aPL antibodies in autoimmune diseases. Semin Arthritis Rheum 31:256-263. Copyright 2002, Elsevier Science (USA). All rights reserved. |
---|---|
ISSN: | 0049-0172 1532-866X |
DOI: | 10.1053/sarh.2002.28303 |